Stoichiometry of multi-specific immune checkpoint RNA Abs for T cell activation and tumor inhibition using ultra-stable RNA nanoparticles
Immunotherapy has become a revolutionary subject in cancer therapy during the past few years. Immune checkpoint-targeting antibodies (Abs) could boost anticancer immune responses. However, certain protein-based immunotherapies revealed side effects and unfavorable biodistribution, so effective non-p...
Main Authors: | Dan Shu, Long Zhang, Xuefeng Bai, Jianhua Yu, Peixuan Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253121000780 |
Similar Items
-
Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles
by: Sijin Guo, et al.
Published: (2017-12-01) -
Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles
by: Linlin Yang, et al.
Published: (2023-09-01) -
Advancements in 3WJ-based RNA nanotechnology and its application for cancer diagnosis and therapy
by: Xin Liu, et al.
Published: (2022-02-01) -
The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
by: Fatimat Kipkeeva, et al.
Published: (2022-08-01) -
RNA nanotechnology and therapeutics /
by: Guo, Peixuan, editor, et al.
Published: (2014)